Gene Query: TINF2

Dataset Description Geneva Score
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 33.38
Genome wide expression change in LCC2 and MCF-7 cells 29.65
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 28.51
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 25.22
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 23.34
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 23.34
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 22.45
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 22.15
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 16.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 16.25
Stem and effector CD8 T-cells from human cancers 15.03
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 14.64
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 14.64
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 14.1
BAF controls genome accessibility 14.09
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 12.61
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 12.61
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 11.95
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 10.29
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 10.29
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 10.17
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 10.08
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 10.08
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 9.37
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 9.34
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 9.26
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 9.18
LNCaP treated with iBET 9.13
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 9.07
Transcriptome of diurnal human blood neutrophils 9.07
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 8.65
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.64
Total RNA-seq in ALL-SIL upon JQ1 inhibition 8.51
Triple vectors expand AAV transfer capacity in the retina 8.43
Human Treg NaCl stimulation 8.28
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 8.27
Effects of rFVIIIFc on human macrophages 8.2
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 8.02
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 7.88
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.53
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 7.51
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 7.42
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 7.39
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 7.34
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 7.13
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 7.0
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 7.0
Short and Long RNA sequencing of human mature erythrocytes 6.81
mRNA expression profile of Lymphocytes by high-throuput sequencing 6.78
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.66
Trans-differentiation of human adult peripheral blood T cells into neurons 6.6
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.57
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.52
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 6.46
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 6.43
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.42
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 6.4
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.39
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 6.39
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.35
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.35
Generation and persistence of human tissue-resident memory T cells in lung transplantation 6.34
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 6.29
Transcriptome analysis of CNS leukemia 6.29
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.18
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.18
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 6.08
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 6.08
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 5.98
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 5.98
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.97
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 5.91
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 5.82
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 5.8
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 5.78
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.75
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 5.67
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 5.62
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.56
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 5.56
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 5.55
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 5.53
Expression data from miR340 overexpressing human A549 cells 5.38
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 5.36
The evolution of N6-methyladenosine in primates 5.36
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 5.35
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 5.35
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 5.34
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 5.34
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 5.29
RNA-seq differential expression studies: more sequence, or more replication? 5.18
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 5.17
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 5.12
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 5.11
Landscape of H3K4me3 in human CD19 cells 5.08
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.06
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 5.05
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.0
A map of gene expression in neutrophil-like cell lines 4.94
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 4.93
The circadian transcriptional landscape in primary human mammary epithelial cells 4.89
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.88
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.88
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 4.88
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 4.87
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.84
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.83
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.81
Noncoding regions are the main source of targetable tumor-specific antigens 4.76
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.75
T47D RNA-seq and ChrRNA-seq data 4.75
Transcriptomic analysis of human tonsillar TFH subsets 4.73
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 4.73
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 4.73
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 4.67
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.61
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.61
Tumor exosome integrins determine organotropic metastasis 4.59
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 4.56
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 4.55
Macrophage Ad5f35 M2 Challenge 4.55
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 4.55
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.53
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.51
Seletive inhibition of CDK9 in DLBCL cell lines 4.46
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.46
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 4.39
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 4.37
IDH3a KO RNA-seq 4.33
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.29
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.29
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.25
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 4.23
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.22
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 4.17
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.14
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 4.13
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 4.09
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 4.08
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 4.08
Accurate annotation of human protein-coding small open reading frames 4.07
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 4.07
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.06
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 4.04
Transcriptome analysis of Zika infected neural stem cells 3.99
Zika infected neural stem cells 3.99
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.96
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.95
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.94
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 3.93
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.9
Functional role of SLIT2 and ROBO1 in trophoblasts 3.87
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 3.87
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.87
Identification of global regulators of T-helper cell lineage specification 3.87
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.85
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.83
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.81
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.78
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 3.78
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.77
CROP-Seq in Primary Human T Cells 3.73
RNA-seq of naive and primed ES cells (NHSM) 3.72
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 3.71
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 3.71
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 3.71
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.7
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.67
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.67
The effect of PPARG inhibition on human angiomyolipoma cells 3.64
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.63
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 3.63
The comparison of high-throughput single-cell RNA-seq methods 3.59
Tracking of dCas9-methyltransferase footprints 3.58
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 3.57
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 3.57
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 3.57
RNAseq of IL-36 stimulated primary human keratinocytes 3.56
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 3.56
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.56
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 3.53
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.5
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.49
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.49
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.49
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 3.49
Intron retention induced by microsatellite expansions as a disease biomarker. 3.46
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 3.46
Chromatin-informed inference of transcriptional programs in gynecologic cancers 3.46
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 3.45
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 3.45
LncRNA expression profiling of ischemic stroke patients 3.43
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 3.43
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.43
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.37
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.37
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.37
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.37
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.37
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.36
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.36
Single-cell analysis of adult human ovary using 10X genomics 3.35
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.35
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 3.34
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 3.32
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.32
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.31
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.31
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 3.3
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.29
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 3.27
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 3.25
Fbxo32 mediated gene expression program underlies EMT and metastasis 3.24
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.23
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 3.23
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.22
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.22
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.22
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 3.22
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 3.22
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.2
RNAseq Study in CC-671 Treated Cal-51 Cells 3.19
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.17
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.17
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.15
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.14
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.14
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.14
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 3.14
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.12
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 3.09
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.08
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 3.04
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.99
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.98
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.98
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.96
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.95
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 2.93
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.89
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 2.88
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.85
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.85
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.83
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.82
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.8
The cohesin complex prevents Myc-induced replication stress 2.79
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.78
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.78
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.76
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 2.75
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 2.75
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.73
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 2.71
Genome-wide transcriptional response to random aneuploidy in human cells 2.68
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 2.64
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 2.63
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.6
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.6
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.6
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.59
RNA-sequencing in immortalized human mammary epithelial cells 2.59
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.58
BACH2 in human plasma cell fate decision 2.56
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.56
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.55
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.54
Macrophage Ad5f35 PhenoMap 2.53
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.52
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.52
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.52
LIN28A Over-expression RNAseq 2.51
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 2.5
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.48
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.46
RNA Seq of HMVEC under hypoxia 2.43
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 2.43
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.41
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.4
Transcriptional effect of ETV1 knockdown in melanoma cells 2.37
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.35
RNAseq of cell lines with knocked in ESR1 mutations 2.35
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.34
TFAP2C signalling in human fibroblasts 2.3
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.28
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 2.24
Glioblastoma stem cells infected by ZIKA virus 2.23
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.23
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.23
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 2.23
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 2.21
Transcriptomic profiling of human peripheral blood-derived mast cells 2.2
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 2.2
Functional significance of the HIV-1 Tat signature amino acid residues 2.18
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.13
Transcriptome analysis of peripheral blood monocytes 2.13
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.11
Total RNA-Seq data from leukemic patients with complex structural variants 2.09
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.08
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 2.08
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 2.08
Expression profiling of MCF-7 cells with treatment of TCDD 2.05
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.05
Gene expression activation in CLL mediated by MSCs contact 2.0
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 2.0
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 2.0
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.99
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.99
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 1.99
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.95
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.94
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.94
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.93
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.87
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.87
Dynamic 3D chromosomal landscapes in acute leukemia 1.85
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.85
Interaction between mitoNEET and NAF-1 in cancer cells 1.84
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.82
RNAseq of T-ALL upon long non coding rna purturbation 1.79
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.78
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.77
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 1.76
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.73
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 1.68
Iron response of HepG2 cells 1.65
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 1.63
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 1.63
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.63
mRNA expression profile of Lymphocytes 1.63
Discovering human diabetes-risk gene function with genetics and physiological assays 1.62
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.62
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.6
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.6
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.58
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.56
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.55
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.54
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.53
Energy Metabolism during Anchorage-Independence 1.51
X-Ray induced DNA-Hydroxymethylation changes 1.51
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.48
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.45
Anti-inflammatory effect of indoleacrylic acid (IA) 1.44
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.44
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.42
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.41
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.41
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.41
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.41
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.4
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.39
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.39
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 1.38
O-glcnAc reprograms cellular energetics 1.37
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.36
RNA-seq of IL-4 stimulated human keratinocytes 1.36
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.35
Human Treg IL-12 stimulation 1.35
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 1.35
Expression profiling of converted and control dermal BJ fibroblasts 1.35
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.34
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.33
Loss of CREBBP results in gene expression repression in lymphoma cells 1.33
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.32
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.31
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.29
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.26
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.25
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.24
RNA-seq of resting and activated CD4+ T cells +-JQ1 1.23
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.21
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 1.2
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 1.19
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.18
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.16
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.11
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.1
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.09
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.09
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.09
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 1.08
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 1.08
Aging-associated patterns in the expression of human endogenous retroviruses 1.05
Downregulation of DDX5/DDX17 and REST 1.03
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.03
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 1.0
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.0
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.96
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.93
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.93
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.92
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.92
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.91
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.91
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 0.89
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.88
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.88
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.87
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.87
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.86
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.86
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.86
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.86
RNA editing in nascent RNA affects pre-mRNA splicing 0.86
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.86
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.84
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.84
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.81
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.81
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.8
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.79
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.78
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.78
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.76
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.75
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 0.74
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.74
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.72
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.7
Effect of nuclear IL-33 on gene expression 0.69
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.69
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.66
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.64
Human Treg IFNg/IL-10 subpopulations 0.63
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.63
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.62
An optimization system for isolating and sequencing of single human colon cancer cells 0.61
The Genetic Landscape of Diamond-Blackfan Anemia 0.61
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.61
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.6
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.6
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.59
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.58
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.58
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.58
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.57
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.56
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.55
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.55
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.55
HNRNPM-regulated splicing dependencies in prostate cancer 0.55
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.51
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.5
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.46
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.46
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.45
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 0.45
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 0.45
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.44
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.44
Dermal endothelial cells of type 2 diabetic patients 0.43
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.41
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.41
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.4
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.4
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.39
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.38
miRNAs affected by antagomiR-17 treatment 0.34
RNA-seq analysis of differentiating human erythroblasts 0.3
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.28
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.28
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.28
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.27
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.26
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.25
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.25
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.25
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.25
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.23
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.23
Oncogenic roles of ARID5B in T-ALL 0.23
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.22
Identification of a LIF-responsive replication-competent human β cell 0.22
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.21
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.21
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.2
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.19
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.19
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.16
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.16
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.15
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.13
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.13
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.12
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.12
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.11
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.1
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.09
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.08
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.06
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.05
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.05
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.05
RNA-Seq from human ILC transitional populations 0.04
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.04
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.04
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.03
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 0.01
Regulatory network controlling tumor-promoting inflammation in human cancers 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation